Vaughan Nelson Investment Management »

United Therapeutics Corporation shares owned by Vaughan Nelson Investment Management

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Vaughan Nelson Investment Management from 13F filings

Historical chart of Vaughan Nelson Investment Management investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Vaughan Nelson Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Vaughan Nelson Investment Management

Quarter filed Position value Share count Share price at filing
2025-03-31 $101M 329k 308.27

More positions owned by Vaughan Nelson Investment Management

Alphabet Inc-cl A Common (GOOGL)
Nvidia Corp Common (NVDA)
Amazon.com Common (AMZN)
Eli Lilly & Co Common (LLY)
Microsoft Corp Common (MSFT)
Monolithic Power Systems Common (MPWR)
Taiwan Semiconductor-sp Adr (TSM)
Ishares Russell 2000 Value Index Fund Exchange Traded Funds (IWN)
Broadcom Common (AVGO)
Meta Platforms Inc-a Common (META)
Jp Morgan Chase & Co Common (JPM)
Zions Bancorp Common (ZION)
Apple Common (AAPL)
United Rentals Common (URI)
Cushman & Wakefield Common

View all positions for Vaughan Nelson Investment Management

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
venBio Select Advisor
Renaissance Technologies
State Street Corporation
Wellington Management Company
Susquehanna International
Geode Capital Management
AQR Capital Management
Darwin Global Management
Invesco
Assetmark
Caption Management
Dimensional Fund Advisors
LMR Partners

View all funds holding United Therapeutics Corporation